Muscarinic Mysteries
A surprising connection emerges between a drug initially shelved for Alzheimer's and its potential to reduce psychosis in schizophrenia. By targeting muscarinic receptors, researchers discovered a unique solution that required a clever combination of medications to mitigate gastrointestinal side effects. This innovative approach highlights the complexities of psychiatric treatment and the serendipity that can lead to groundbreaking discoveries.In this clip
From this podcast
Short Wave
A Brand New Kind of Schizophrenia Treatment
Related Questions